About this Journal Submit a Manuscript Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 534934, 11 pages
http://dx.doi.org/10.1155/2012/534934
Research Article

Isoliquiritigenin-Induced Differentiation in Mouse Melanoma B16F0 Cell Line

1Key Laboratory of Xinjiang Endemic Phytomedicine Resources of Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832002, China
2Lanzhou University Second Hospital, Lanzhou University, Lanzhou 730000, China
3Life Science School, Yantai University, Yantai 264000, China

Received 5 September 2012; Revised 3 November 2012; Accepted 8 November 2012

Academic Editor: Jing Yi

Copyright © 2012 Xiaoyu Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Hoeng and L. F. Eichenfield, “The rising incidence of melanoma in children and adolescents,” Dermatology Nursing, vol. 12, pp. 188–193, 2000.
  2. W. Englaro, R. Rezzonico, M. Durand-Clement, D. Lallemand, J. P. Ortonne -, and R. Ballotti, “Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells,” The Journal of Biological Chemistry, vol. 270, no. 41, pp. 24315–24320, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Buscà, C. Bertolotto, J. P. Ortonne, and R. Ballotti, “Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation,” The Journal of Biological Chemistry, vol. 271, no. 50, pp. 31824–31830, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Englaro, C. Bertolotto, R. Buscà et al., “Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation,” The Journal of Biological Chemistry, vol. 273, no. 16, pp. 9966–9970, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Zhao, Y. Wakamatsu, M. Shibahara et al., “Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture,” Cancer Research, vol. 59, no. 2, pp. 482–486, 1999. View at Scopus
  6. M. B. Sporn and A. B. Roberts, “Role of retinoids in differentiation and carcinogenesis,” Cancer Research, vol. 43, no. 7, pp. 3034–3040, 1983. View at Scopus
  7. Y. Zhao, J. Liu, and K. E. McMartin, “Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells,” Oncology Reports, vol. 19, no. 5, pp. 1225–1230, 2008. View at Scopus
  8. J. Smith, E. Ladi, M. Mayer-Pröschel, and M. Noble, “Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 10032–10037, 2000. View at Scopus
  9. D. K. S. Clair, T. D. Oberley, K. E. Muse, and W. H. S. Clair, “Expression of manganese superoxide dismutase promotes cellular differentiation,” Free Radical Biology and Medicine, vol. 16, no. 2, pp. 275–282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. C. Gutteridge and B. Halliwell, “Free radicals and antioxidants in the year 2000. A historical look to the future,” Annals of the New York Academy of Sciences, vol. 899, pp. 136–147, 2000. View at Scopus
  11. Y. M. Kim, T. H. Kim, Y. W. Kim et al., “Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition,” Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1722–1734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. V. R. Yadav, S. Prasad, B. Sung, and B. B. Aggarwal, “The role of chalcones in suppression of NF-κB-mediated inflammation and cancer,” International Immunopharmacology, vol. 11, no. 3, pp. 295–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Shibata, “A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice,” Yakugaku Zasshi, vol. 120, no. 10, pp. 849–862, 2000. View at Scopus
  14. A. D. Kinghorn, B. N. Su, S. J. Dae et al., “Natural inhibitors of carcinogenesis,” Planta Medica, vol. 70, no. 8, pp. 691–705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Yuan, B. Zhang, N. Chen et al., “Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells,” Journal of Asian Natural Products Research, vol. 14, no. 8, pp. 789–798, 2012. View at Publisher · View at Google Scholar
  16. D. Li, Z. Wang, H. Chen et al., “Isoliquiritigenin induces monocytic differentiation of HL-60 cells,” Free Radical Biology and Medicine, vol. 46, no. 6, pp. 731–736, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Scopus
  18. Y. Liang, X. Hou, Q. Cui et al., “Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma,” Journal of Translational Medicine, vol. 18, pp. 10–73, 2012.
  19. D. Alesiani, R. Cicconi, M. Mattei, C. Montesano, R. Bei, and A. Canini, “Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines,” International Journal of Oncology, vol. 32, no. 2, pp. 425–434, 2008. View at Scopus
  20. M. Y. Choi, H. S. Song, H. S. Hur, and S. S. Sim, “Whitening activity of luteolin related to the inhibition of cAMP pathway in α-MSH-stimulated B16 melanoma cells,” Archives of Pharmacal Research, vol. 31, no. 9, pp. 1166–1171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. M. Choi, H. J. Jun, K. Dawson et al., “Effects of the isoflavone puerarin and its glycosides on melanogenesis in B16 melanocytes,” European Food Research and Technology, vol. 231, no. 1, pp. 75–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. L. Pan, S. Zheng, Z. X. Xiao, J. Cao, and H. P. Yao, “Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice,” Zhonghua yi xue za zhi, vol. 83, no. 1, pp. 51–54, 2003. View at Scopus
  23. V. G. Martinez, K. J. Williams, I. J. Stratford, M. Clynes, and R. O'Connor, “Overexpression of cytochrome P450 NADPH reductase sensitises MDA 231 breast carcinoma cells to 5-fluorouracil: Possible mechanisms involved,” Toxicology in Vitro, vol. 22, no. 3, pp. 582–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Umek, A. D. Friedman, and S. L. McKnight, “CCAAT-enhancer binding protein: a component of a differentiation switch,” Science, vol. 251, no. 4991, pp. 288–292, 1991. View at Scopus
  25. P. Valverde, J. C. Garcia-Borron, C. Jimenez-Cervantes, F. Solano, and J. A. Lozano, “Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by α-melanocyte-stimulating hormone,” European Journal of Biochemistry, vol. 217, no. 2, pp. 541–548, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Gismondi, A. Lentini, C. Tabolacci, B. Provenzano, and S. Beninati, “Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells,” Amino Acids, vol. 38, no. 1, pp. 257–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Iozumi, G. E. Hoganson, R. Pennella, M. A. Everett, and B. B. Fuller, “Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes,” Journal of Investigative Dermatology, vol. 100, no. 6, pp. 806–811, 1993. View at Scopus
  28. D. W. Hedley, E. A. McCulloch, M. D. Minden, S. Chow, and J. Curtis, “Antileukemic action of buthionine sulfoximine: evidence for an intrinsic death mechanism based on oxidative stress,” Leukemia, vol. 12, no. 10, pp. 1545–1552, 1998. View at Scopus
  29. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Bedard and K. H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. J. Kim, “Antimelanogenic and antioxidant properties of gallic acid,” Biological and Pharmaceutical Bulletin, vol. 30, no. 6, pp. 1052–1055, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Leszczyniecka, T. Roberts, P. Dent, S. Grant, and P. B. Fisher, “Differentiation therapy of human cancer: basic science and clinical applications,” Pharmacology and Therapeutics, vol. 90, no. 2-3, pp. 105–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Pan and S. C. J. Yeung, “Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors,” Cancer Research, vol. 65, no. 20, pp. 9109–9112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. W. C. Chou, C. Jie, A. A. Kenedy, R. J. Jones, M. A. Trush, and C. V. Dang, “Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4578–4583, 2004. View at Publisher · View at Google Scholar · View at Scopus